| 1SEQ | L:1-106A | FAB MNAC13 |
| 1WC7 | A:1-107; L:1-107 | FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE |
| 1WCB | A:1-107; L:1-107 | PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN |
| 1XGP | A:0-107 | STRUCTURE FOR ANTIBODY HYHEL-63 Y33A MUTANT COMPLEXED WITH HEN EGG LYSOZYME |
| 1XGQ | A:0-107 | STRUCTURE FOR ANTIBODY HYHEL-63 Y33V MUTANT COMPLEXED WITH HEN EGG LYSOZYME |
| 1XGR | A:0-107 | STRUCTURE FOR ANTIBODY HYHEL-63 Y33I MUTANT COMPLEXED WITH HEN EGG LYSOZYME |
| 1XGT | A:0-107 | STRUCTURE FOR ANTIBODY HYHEL-63 Y33L MUTANT COMPLEXED WITH HEN EGG LYSOZYME |
| 1YJD | L:1-107 | CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1) |
| 1YNT | A:1-107; C:1001-1107 | STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY |
| 1YQV | L:0-107 | THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION |
| 1YY9 | C:1-107; C:108-211 | STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF CETUXIMAB/ERBITUX/IMC-C225 |
| 1Z5L | A:186-279; C:186-279 | STRUCTURE OF A HIGHLY POTENT SHORT-CHAIN GALACTOSYL CERAMIDE AGONIST BOUND TO CD1D |
| 1ZHN | A:186-279 | CRYSTAL STRUCTURE OF MOUSE CD1D BOUND TO THE SELF LIGAND PHOSPHATIDYLCHOLINE |
| 1ZOX | A: | CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN |
| 1ZTX | L:1-107 | WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB |
| 2A1W | L:114-216; M:114-216 | ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM I |
| 2A6J | A:1-107; L:1-107 | CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 |
| 2A77 | L:114-216 | ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM II |
| 2ADG | A:1-107 | CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 |
| 2ADI | A:1-107 | CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM |
| 2ADJ | A:1-107 | CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM |
| 2AEP | L:1-107 | AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX. |
| 2AEQ | L: | AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX. |
| 2AI0 | L:114-217; M:114-217; N:114-216; O:114-217 | ANTI-COCAINE ANTIBODY 7.5.21, CRYSTAL FORM III |
| 2AJS | L:1-107 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH HEPTAETHYLENE GLYCOL |
| 2AJU | L:1-107 | CYRSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' |
| 2AJV | L:1-107 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH COCAINE |
| 2AJX | L:1-107 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH TRANSITION STATE ANALOG |
| 2AJY | L:1-107 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER AND BENZOIC ACID |
| 2AJZ | A:1-107; L:1-107 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH ECGONINE METHYL ESTER |
| 2AK1 | L:1-107 | CRYSTAL STRUCTURE OF COCAINE CATALYTIC ANTIBODY 7A1 FAB' IN COMPLEX WITH BENZOIC ACID |
| 2B2X | L:1-114; M:1-114 | VLA1 RDELTAH I-DOMAIN COMPLEXED WITH A QUADRUPLE MUTANT OF THE AQC2 FAB |
| 2BMK | A:1-107; L:1-107 | FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE |
| 2BOC | B:1-107 | POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS) |
| 2C1O | A:1-107; A:108-212; L:1-107; L:108-212 | ENAIIHIS FAB FRAGMENT IN THE FREE FORM |
| 2C1P | A:1-107; L:2-107 | FAB-FRAGMENT OF ENANTIOSELECTIVE ANTIBODY COMPLEXED WITH FINROZOLE |
| 2D03 | L:115-218 | CRYSTAL STRUCTURE OF THE G91S MUTANT OF THE NNA7 FAB |
| 2E27 | L: | CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN |
| 2EH7 | L:1-107 | CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB |
| 2EXY | D:1-106; F:1-106 | CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC, FAB COMPLEXED IN ABSENCE OF BOUND IONS |
| 2FAT | L:1-106A | AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE |
| 2FIK | A:186-279 | STRUCTURE OF A MICROBIAL GLYCOSPHINGOLIPID BOUND TO MOUSE CD1D |
| 2G2R | A:1-107; L:1-107 | GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE) |
| 2G60 | L:109-208 | STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN |
| 2GCY | A:1-110 | HUMANIZED ANTIBODY C25 FAB FRAGMENT |
| 2GJJ | A:-1-114; A:136-253; B:-1-113; B:136-253 | CRYSTAL STRUCTURE OF A SINGLE CHAIN ANTIBODY SCA21 AGAINST HER2/ERBB2 |
| 2GJZ | A:109-212; L:109-212 | STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A CRYSTAL IN SPACE GROUP P2(1) |
| 2GK0 | A:109-212; L:109-212 | STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2 |
| 2GKI | A:23-132; A:159-273; B:23-132; B:159-274 | HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY |
| 2GSG | A:; C: | CRYSTAL STRUCTURE OF THE FV FRAGMENT OF A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE |
| 2H2P | D:1-106; F:1-106 | CRYSTAL STRUCTURE OF CLC-EC1 IN COMPLEX WITH FAB FRAGMENT IN SECN- |
| 2H2S | D:1-106; F:1-106 | CRYSTAL STRUCTURE OF E148A MUTANT OF CLC-EC1 IN SECN- |
| 2I9L | A:1-112; C:1-112; E:1-112; G:1-112 | STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN |
| 2J4W | L:1-107 | STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX |
| 2J5L | B:1-107 | STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX |
| 2LQR | A: | NMR STRUCTURE OF IG3 DOMAIN OF PALLADIN |
| 2NR6 | C:1-107; E:1-107 | CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2 |
| 2O5X | L:108-213 | CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP, AN ENGINEERED DIELS-ALDERASE FAB WITH NM STEROID-BINDING AFFINITY |
| 2O5Y | L:108-213 | CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX |
| 2O5Z | L:108-213 | CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA-ANDROSTANE-3,17-DIONE COMPLEX |
| 2OR7 | A:; B: | TIM-2 |
| 2OR8 | A:; B: | TIM-1 |
| 2OYP | A: | T CELL IMMUNOGLOBULIN MUCIN-3 CRYSTAL STRUCTURE REVEALED A GALECTIN-9-INDEPENDENT BINDING SURFACE |
| 2OZ4 | L:1-107 | STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION |
| 2P1Y | E:302-412; G:302-412 | 1.B2.D9, A BISPECIFIC ALPHA/BETA TCR |
| 2Q86 | A:0-110; A:111-191; B:3-111; C:0-110; C:111-192; D:3-111 | STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14 |
| 2Q8A | L:1-107 | STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY |
| 2Q8B | L:1-107 | STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH-INHIBITORY ANTIBODY |
| 2R29 | L:1-111 | NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY |
| 2R9H | D:1-106; F:1-106 | CRYSTAL STRUCTURE OF Q207C MUTANT OF CLC-EC1 IN COMPLEX WITH FAB |
| 2RGS | A:237-339; A:340-442; B:237-339; B:340-443 | FC-FRAGMENT OF MONOCLONAL ANTIBODY IGG2B FROM MUS MUSCULUS |
| 2V17 | L:1-107 | STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN |
| 2V7H | A:1-107; L:1-107 | CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI-MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT |
| 2VC2 | L:1-107 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758 |
| 2VDK | L:1-107 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE |
| 2VDL | L:1-107 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE |
| 2VDM | L:1-107 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN |
| 2VDN | L:1-107 | RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE |
| 2VL5 | B:1-111; D:1-111 | STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1 |
| 2VXT | L:1-107 | CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB |
| 2VXU | L:1-107; M:1-107 | CRYSTAL STRUCTURE OF MURINE REFERENCE ANTIBODY 125-2H FAB FRAGMENT |
| 2W60 | B:1-112 | ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 |
| 2W9D | L:1-106 | STRUCTURE OF FAB FRAGMENT OF THE ICSM 18 - ANTI-PRP THERAPEUTIC ANTIBODY AT 1.57 A RESOLUTION. |
| 2W9E | L:1-109 | STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231 |
| 2XKN | A:1-107; C:1-107 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-EGFR ANTIBODY 7A7 |
| 2XQY | K:1-107; L:1-107 | CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3 |
| 2YMX | L:1-107; L:108-213 | CRYSTAL STRUCTURE OF INHIBITORY ANTI-ACHE FAB408 |
| 2YPV | L:1-107 | CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY |
| 2YZ1 | A:; B: | CRYSTAL STRUCTURE OF THE LIGAND-BINDING DOMAIN OF MURINE SHPS-1/SIRP ALPHA |
| 2Z91 | B:1-107; D:1-107 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 |
| 2Z92 | B:1-107 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE |
| 2ZCH | L:1-107 | CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY |
| 3AB0 | C:; F: | CRYSTAL STRUCTURE OF COMPLEX OF THE BACILLUS ANTHRACIS MAJOR SPORE SURFACE PROTEIN BCLA WITH SCFV ANTIBODY FRAGMENT |
| 3ARB | C:1-117; D:3-118 | TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH |
| 3ARD | C:1-117; D:3-118; D:119-247 | TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3'DEOXY-ALPHA-GALACTOSYLCERAMIDE |
| 3ARE | C:1-117; D:3-118 | TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4'DEOXY-ALPHA-GALACTOSYLCERAMIDE |
| 3ARF | C:1-117; D:4-118 | TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2 |
| 3ARG | C:1-117; D:3-118; D:119-246 | TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA-GLUCOSYLCERAMIDE(C20:2) |
| 3AXL | A:3-129; B:3-129; G:3-129; H:3-129 | MURINE VALPHA 10 VBETA 8.1 T-CELL RECEPTOR |
| 3BGF | C:1-107; L:1-107 | X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB |
| 3BI9 | X: | TIM-4 |
| 3BIA | X: | TIM-4 IN COMPLEX WITH SODIUM POTASSIUM TARTRATE |
| 3BIB | X: | TIM-4 IN COMPLEX WITH PHOSPHATIDYLSERINE |
| 3BKC | L:1-106A; L:107-212 | CRYSTAL STRUCTURE OF ANTI-AMYLOID BETA FAB WO2 (P21, FORMB) |
| 3BKM | L:1-106A; L:107-212 | STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A, P212121) |
| 3BQU | C:1-104; C:108-209 | CRYSTAL STRUCTURE OF THE 2F5 FAB'-3H6 FAB COMPLEX |
| 3BT2 | L:1-106A | STRUCTURE OF UROKINASE RECEPTOR, UROKINASE AND VITRONECTIN COMPLEX |
| 3BZ4 | A:1-107; C:1-107; E:1-107; G:1-107 | CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG DECASACCHARIDE |
| 3C5S | A:1-107; C:1-107 | CRYSTAL STRUCTURE OF MONOCLONAL FAB F22-4 SPECIFIC FOR SHIGELLA FLEXNERI 2A O-AG |
| 3C5Z | A:1-112; B:1-112; E:1-112; F:1-112 | CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506 |
| 3C60 | A:1-111; B:1-111; E:1-111; F:1-111 | CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62 |
| 3C6S | A:1-107; C:1-107; E:1-107; G:1-107 | CRYSTAL STRUCTURE OF FAB F22-4 IN COMPLEX WITH A SHIGELLA FLEXNERI 2A O-AG PENTADECASACCHARIDE |
| 3CFB | A:1-107; L:1-107 | HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 IN COMPLEX WITH STILBENE HAPTEN AT 100K |
| 3CFC | L:1-107 | HIGH-RESOLUTION STRUCTURE OF BLUE FLUORESCENT ANTIBODY EP2-19G2 |
| 3CFD | A:1-107; L:1-107 | PURPLE-FLUORESCENT ANTIBODY EP2-25C10 IN COMPLEX WITH ITS STILBENE HAPTEN |
| 3CFE | A:1-107; L:1-107 | CRYSTAL STRUCTURE OF PURPLE-FLUORESCENT ANTIBODY EP2-25C10 |
| 3CFJ | A:1-106; C:1-106; E:1-106; L:1-106 | CRYSTAL STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 34E4, ORTHORHOMBIC CRYSTAL FORM |
| 3CMO | L:1-107; X:2-107 | HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18 |
| 3CVH | L:1-106; R:1-106 | HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE |
| 3CVI | L:1-106 | HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE |
| 3D9A | L:1-107 | HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME |
| 3E8U | L:1-107 | CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION |
| 3EFD | L:1-107 | THE CRYSTAL STRUCTURE OF THE CYTOPLASMIC DOMAIN OF KCSA |
| 3EOT | L:1-111 | CRYSTAL STRUCTURE OF LAC031, AN ENGINEERED ANTI-VLA1 FAB |
| 3ESU | F:1-106; F:1004-1113 | CRYSTAL STRUCTURE OF ANTHRAX-NEUTRALIZING SINGLE-CHAIN ANTIBODY 14B7 |
| 3ESV | F:-1-106; F:1002-1113; G:-1-106; G:1003-1113 | CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18 |
| 3ET9 | F:0-106; F:1003-1113 | CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY 1H |
| 3FB6 | B:1-107 | KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112 |
| 3FFD | B:1-116; B:117-217 | STRUCTURE OF PARATHYROID HORMONE-RELATED PROTEIN COMPLEXED TO A NEUTRALIZING MONOCLONAL ANTIBODY |
| 3FO0 | L:113-216 | CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE) |
| 3FO1 | A:113-216; L:113-216 | CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT) |
| 3FO2 | A:113-216; L:113-216 | CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT) |
| 3G5Z | A:1-110 | ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR |
| 3GI8 | L:1-113 | CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT |
| 3GI9 | L:1-113 | CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT |
| 3GK8 | L:1-107; L:108-214 | X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14, MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS |
| 3GKZ | A:9-116; A:143-250 | CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN COMPLEX METHAMPHETAMINE |
| 3GM0 | A:9-125; A:142-250 | ANTI-METHAMPHETAMINE SINGLE CHAIN FV IN COMPLEX WITH MDMA |
| 3GML | A:186-281 | STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C6PH |
| 3GMM | A:186-281 | STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH |
| 3GMN | A:186-281 | STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C10PH |
| 3GMO | A:186-281 | STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PHF |
| 3GMP | A:186-281 | STRUCTURE OF MOUSE CD1D IN COMPLEX WITH PBS-25 |
| 3GMQ | A:186-281 | STRUCTURE OF MOUSE CD1D EXPRESSED IN SF9 CELLS, NO LIGAND ADDED |
| 3GMR | A:186-279 | STRUCTURE OF MOUSE CD1D IN COMPLEX WITH C8PH, DIFFERENT SPACE GROUP |
| 3H3B | C:-2-112; C:136-253; D:-2-113; D:136-253 | CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV (SCFV) FRAGMENT OF AN ANTI-ERBB2 ANTIBODY CHA21 IN COMPLEX WITH RESIDUES 1-192 OF ERBB2 EXTRACELLULAR DOMAIN |
| 3HE6 | A:186-299; C:1-117; D:3-118 | CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR |
| 3HE7 | A:186-299; C:1-117; D:2-118; D:119-247 | CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR |
| 3HNS | L:1-107 | CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE |
| 3HNT | L:1-107 | CS-35 FAB COMPLEX WITH A LINEAR, TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN |
| 3HNV | L:1-107 | CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE) |
| 3HZK | A:1-106 | CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO |
| 3HZM | A:1-106 | CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO |
| 3HZV | A:1-106 | CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO |
| 3HZY | A:1-106 | CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO |
| 3I02 | A:1-106; C:1-106 | CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO |
| 3I2C | L:1-111 | CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO4088 |
| 3I50 | L:1-107 | CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB |
| 3I75 | A:1-107 | ANTIBODY STRUCTURE |
| 3I9G | L:1-107 | CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE |
| 3IF1 | A:113-212; C:113-212 | CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC |
| 3IJH | A:2-106; C:2-106 | STRUCTURE OF S67-27 IN COMPLEX WITH KO |
| 3IJS | A:2-106; C:2-106 | STRUCTURE OF S67-27 IN COMPLEX WITH TSBP |
| 3IJY | A:2-106; C:2-106 | STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO |
| 3IKC | A:2-106; C:2-106 | STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO |
| 3IU4 | L:1-107 | ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3 |
| 3IVK | B:1-108; L:1-108 | CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT |
| 3IXT | B:1-107; L:1-107 | CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE |
| 3KAA | A:; B: | STRUCTURE OF TIM-3 IN COMPLEX WITH PHOSPHATIDYLSERINE |
| 3KHO | A:; B: | CRYSTAL STRUCTURE OF MURINE IG-BETA (CD79B) HOMODIMER |
| 3KHQ | A: | CRYSTAL STRUCTURE OF MURINE IG-BETA (CD79B) IN THE MONOMERIC FORM |
| 3KJ4 | B:1-112; L:1-112 | STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY |
| 3KS0 | J:1-110; J:111-212; L:1-110; L:111-212 | CRYSTAL STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME B2 IN COMPLEX WITH FAB B2B4 |
| 3L1O | L:1-107 | CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC |
| 3L5W | A:1-107; L:1-107 | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB |
| 3L7E | A:1-107; L:1-107 | CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836 |
| 3LIZ | L:1-107 | CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3 |
| 3LS4 | L:1-108 | CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC |
| 3LS5 | L:1-108 | ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT, FREE FORM |
| 3MBX | L:1-113 | CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836 |
| 3MCL | L:1-105 | ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21 |
| 3MNV | A:-1-107; A:108-213; C:-1-107; C:108-212 | CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT |
| 3MO1 | A:0-107; A:108-211 | CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT |
| 3MXV | L:1-107 | CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA |
| 3NID | F:1-107; L:1-107 | THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING |
| 3NIF | F:1-107; L:1-107 | THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING |
| 3NIG | F:1-107; L:1-107 | THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING |
| 3O0R | L:1-107 | CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT |
| 3O11 | A:1-105; L:1-105 | ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2 |
| 3O2D | L:1-106 | CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY |
| 3O2V | L:108-213 | CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE, AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY |
| 3O2W | L:108-213 | CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG |
| 3O6K | L:1-112 | CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB'11H6H1 |
| 3O8X | C:1-117 | RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR |
| 3O9W | C:1-117 | RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR |
| 3OJD | A:1-107 | ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT) |
| 3OKD | A:1-107 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO |
| 3OKE | A:1-107 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO |
| 3OKK | A:1-107 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO |
| 3OKL | A:1-107 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO |
| 3OKM | A:1-107 | CRYSTAL STRUCTURE OF UNLIGANDED S25-39 |
| 3OKN | A:1-107 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO |
| 3OKO | A:1-107 | CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO |
| 3OZ9 | L:1-110 | CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1 |
| 3PHO | A:2-110 | CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP |
| 3PHQ | A:2-110 | CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO |
| 3PP3 | K:1-112; L:1-112 | EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES |
| 3PXH | A:30-124; A:125-226 | TANDEM IG DOMAINS OF TYROSINE PHOSPHATASE LAR |
| 3Q3G | A:1-113; C:1-113; F:1-113; J:1-113 | CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY |
| 3Q5T | A:3-115 | V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES |
| 3Q5Y | A:0-117; B:1-117; C:1-117; D:1-117 | V BETA/V BETA HOMODIMERIZATION-BASED PRE-TCR MODEL SUGGESTED BY TCR BETA CRYSTAL STRUCTURES |
| 3QI9 | C:1-117; D:1-118 | CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR |
| 3QIB | D:2-116 | CRYSTAL STRUCTURE OF THE 2B4 TCR IN COMPLEX WITH MCC/I-EK |
| 3QIU | C:2-109; D:2-116 | CRYSTAL STRUCTURE OF THE 226 TCR IN COMPLEX WITH MCC/I-EK |
| 3QJF | A:2-111; B:2-115; B:116-243; C:1-111; D:4-115; D:116-244 | CRYSTAL STRUCTURE OF THE 2B4 TCR |
| 3QJH | A:1-117; B:2-119; C:1-117; D:2-119 | THE CRYSTAL STRUCTURE OF THE 5C.C7 TCR |
| 3QUX | C:1-117; D:113-240 | STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX |
| 3QUY | C:1-117; D:113-240 | STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1'-INKT TCR COMPLEX |
| 3QUZ | C:1-117; D:113-240 | STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX |
| 3QWO | B:1-107; L:1-107 | CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB |
| 3RA7 | L:1-107; M:1-107 | BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY |
| 3RAJ | L:1-105 | CRYSTAL STRUCTURE OF HUMAN CD38 IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY HB7 |
| 3RGV | A:1-110; B:1-112 | A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS |
| 3RKD | C:1-107; L:1-107 | HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY |
| 3RTQ | C:1-117; D:113-240 | STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX |
| 3RUG | E:3-129; F:3-128; G:3-129; H:3-128 | CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D-ALPHAGLUCOSYLCERAMIDE (C20:2) |
| 3RVT | C:1-110 | STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP |
| 3RVU | C:1-110 | STRUCTURE OF 4C1 FAB IN C2221 SPACE GROUP |
| 3RVV | | [entry was replaced by entry 5VPL without any SCOP domain information] |
| 3RVW | | [entry was replaced by entry 5VPG without any SCOP domain information] |
| 3RVX | | [entry was replaced by entry 5VPH without any SCOP domain information] |
| 3RZC | C:1-117; D:113-240 | STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR |
| 3S34 | L:1-107 | STRUCTURE OF THE 1121B FAB FRAGMENT |
| 3S35 | L:1-111 | STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES |
| 3S37 | L:2-107 | STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES |
| 3S96 | B:241-357; B:358-458; D:242-357; D:358-458 | CRYSTAL STRUCTURE OF 3B5H10 |
| 3SCM | C:1-117; D:1-118 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE |
| 3SDA | C:1-117; D:1-118 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE |
| 3SDC | A:186-295; C:1-117; D:1-119 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE |
| 3SDD | A:186-295; C:1-117; D:1-119 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE |
| 3SGD | I:1-112; L:1-112 | CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2 |
| 3SGE | I:1-112; L:1-112 | CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE |
| 3T3M | F:1-107; L:1-107 | A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS |
| 3T3P | F:1-107; L:1-107 | A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS |
| 3TA3 | C:1-117 | STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX |
| 3TO4 | A:186-299 | STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE |
| 3TT1 | L:1-111; M:1-111 | CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB |
| 3TVM | C:1-117; G:1-117 | STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX |
| 3U0W | L:1-107 | AD RELATED MURINE ANTIBODY FRAGMENT |
| 3UBX | A:186-286; D:186-286; I:1-107; L:1-107 | CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX |
| 3UJT | L:1-107; M:1-107 | STRUCTURE OF THE FAB FRAGMENT OF AB-52, AN ANTIBODY THAT BINDS THE O-ANTIGEN OF FRANCISELLA TULARENSIS |
| 3UMT | A:3-113; A:138-244 | SCFV12, ANTI-BCLA ANTIBODY SINGLE CHAIN VARIABLE FRAGMENT |
| 3UTZ | A:113-216; D:113-216; E:113-216 | ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL |
| 3UYP | A:2-117; A:135-244 | CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 4 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 |
| 3UZE | A:2-117; A:133-245; B:2-117; B:134-243 | CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 |
| 3UZQ | A:3-117; A:134-245 | CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 |
| 3UZV | B:2-117; B:133-244 | CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11 |
| 3V0V | B:1-107; L:1-107 | FAB WN1 222-5 UNLIGANDED |
| 3V0W | L:1-107 | CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS |
| 3V4P | L:114-217; N:114-217 | CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 |
| 3V4V | L:114-217; N:114-217 | CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376 |
| 3V6F | B:1-114; D:1-114; F:1-114; L:1-114 | CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6), UNBOUND |
| 3V6O | E:4-109; F:4-109 | LEPTIN RECEPTOR-ANTIBODY COMPLEX |
| 3VFG | L:1-107 | CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE |
| 3VG0 | L:3-109 | ANTIBODY FAB FRAGMENT |
| 3VG9 | B:1-107 | CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION |
| 3VGA | B:1-107 | CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION |
| 3VI3 | E:1-112; L:1-112 | CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM) |
| 3WKM | L:1-111; L:112-215; M:1-111; M:112-214 | THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT |
| 3ZDX | F:1-107; L:1-107 | INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX |
| 3ZKM | D:1-111; L:1-111 | BACE2 FAB COMPLEX |
| 3ZKN | D:1-111; L:1-111 | BACE2 FAB INHIBITOR COMPLEX |
| 3ZO0 | A:237-339; A:340-444 | MOUSE IGG2A IN COMPLEX WITH MOUSE TRIM21 PRYSPRY |
| 4AEH | L:1-107 | CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY |
| 4AG4 | L:1-107 | CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX |
| 4APQ | A:186-295; C:1-119; D:1-118; D:119-244 | CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE |
| 4BA8 | A: | HIGH RESOLUTION NMR STRUCTURE OF THE C MU3 DOMAIN FROM IGM |
| 4C83 | B:1-107; B:108-214; D:2-107; D:108-214 | CRYSTAL STRUCTURE OF THE IGG2A LPT3 IN COMPLEX WITH AN 8-SUGAR INNER CORE ANALOGUE OF NEISSERIA MENINGITIDIS |
| 4CAD | A:2-107; A:108-212; D:2-107; D:108-212; G:1-107; G:108-212; J:1-107; J:108-212 | MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1 |
| 4DCQ | A:1-115; A:116-218 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10, AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM) |
| 4DGI | L:1-107 | STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120-230 |
| 4DVB | B:1-108; L:1-108 | THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112 |
| 4DW2 | L:1-107 | THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB-112 |
| 4EBQ | L:2-110 | FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5 |
| 4EDX | A:1-107; L:1-107 | NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM MOUSE MAB 911 |
| 4EI5 | C:2-114; D:2-115; D:116-243; E:186-290; G:2-114; H:1-115; H:116-237 | CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1 |
| 4EI6 | A:2-114; B:0-115; C:2-114; D:3-115 | STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR |
| 4ELK | A:3-115; B:3-116; C:3-115; D:2-116 | CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR |
| 4ETQ | B:2-110; L:2-110 | VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5 |
| 4F15 | C:1-110; F:1-110; I:1-110; L:1-110 | MOLECULAR BASIS OF INFECTIVITY OF 2009 PANDEMIC H1N1 INFLUENZA A VIRUSES |
| 4F2M | B:1-107; D:1-107 | CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10 |
| 4F33 | A:2-106; C:2-106; E:2-106; G:2-106 | CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009 |
| 4F3F | A:2-106 | CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX |
| 4F9L | C:1-109; C:132-254; D:1-109; D:132-254 | CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY |
| 4FFV | C:1-106; L:1-106 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH 11A19 FAB |
| 4FFW | C:1-106; L:1-106 | CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN |
| 4FG6 | D:1-106; F:1-106 | STRUCTURE OF ECCLC E148A MUTANT IN GLUTAMATE |
| 4GAY | B:1-107; L:1-107 | STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 |
| 4GMS | L:1-107; M:1-107; N:1-107 | CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ |
| 4GMT | L:1-107; M:1-107 | CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 |
| 4GQ9 | L:1-109 | CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT |
| 4H0G | A:1-120; A:140-251 | CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING NATIVE 2D10 SCFV |
| 4H0H | B:1-120; B:140-251 | CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING 2D10 SCFV WITH PEPTIDE |
| 4H0I | A:1-120; A:140-251 | CRYSTAL STRUCTURE OF SCFV-2D10 IN COMPLEX WITH METHYL ALPHA-D-MANNOPYRANOSIDE |
| 4H20 | L:1-107 | CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18 |
| 4H88 | L:1-107 | STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120-230 |
| 4HLZ | H:3-109; J:3-109; L:3-109 | CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ |
| 4HXA | L:1-107 | CRYSTAL STRUCTURE OF 13D9 FAB |
| 4HZL | B:114-217; L:114-217 | NEUTRALIZING ANTIBODY MAB#8 IN COMPLEX WITH THE EPITOPE II OF HCV E2 ENVELOPE PROTEIN |
| 4I9W | D:1-106; F:1-106 | HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE |
| 4IJ3 | B:1-107; B:108-214 | OXIDOREDUCTASE FRAGMENT OF HUMAN QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTI- HUMAN QSOX1 ANTIBODY |
| 4IRJ | A:186-279; C:2-115; D:2-112; D:113-240 | STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX |
| 4IRS | C:1-114 | STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX |
| 4ISV | A:1-116; A:117-217 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE |
| 4J1U | A:1-112; C:1-112; E:3-112 | CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT |
| 4JJ5 | A:1-115; A:119-207 | CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2, A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE |
| 4JN1 | L:2-113 | AN ANTIDOTE FOR DABIGATRAN |
| 4JN2 | A:2-113; L:2-113 | AN ANTIDOTE FOR DABIGATRAN |
| 4JQI | L:1-108 | STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE |
| 4JR9 | L:1-106 | CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK |
| 4JRE | C:1-106; L:1-106 | CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND |
| 4JVU | A:; B: | IGM C2-DOMAIN FROM MOUSE |
| 4JVW | A:; B:; C:; D: | IGM C4-DOMAIN FROM MOUSE |
| 4JZJ | B:1-113; L:1-113 | CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX |
| 4K23 | L:1-107 | STRUCTURE OF ANTI-UPAR FAB ATN-658 |
| 4K2U | L:1-107; L:108-210; M:1-107; M:108-200 | CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT |
| 4K7P | L:1-107 | GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG |
| 4K9E | L:2-110 | CRYSTAL STRUCTURE OF KIT D4D5 FRAGMENT IN COMPLEX WITH ANTI-KIT ANTIBODIES FAB79D |
| 4KI5 | D:1-106; D:107-213; F:1-107 | CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99 |
| 4KJW | D:1-106; F:1-106 | STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE |
| 4KK5 | D:1-106; F:1-106 | STRUCTURE OF THE CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE |
| 4KK6 | D:1-106; F:1-106 | STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE |
| 4KK9 | D:1-106; F:1-106 | STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 2MM BROMIDE |
| 4KKA | D:1-106; F:1-106 | STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 100MM FLUORIDE AND 20MM BROMIDE |
| 4KKB | D:1-106; F:1-106 | STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM FLUORIDE AND 20MM BROMIDE |
| 4KKC | D:1-106; F:1-106 | STRUCTURE OF THE E148A MUTANT OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE |
| 4KPH | L:1-107; M:1-107 | STRUCTURE OF THE FAB FRAGMENT OF N62, A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN |
| 4KQ4 | L:1-107 | CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357 |
| 4KRO | C:1-107; C:108-211 | NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR |
| 4KRP | C:1-107 | NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR |
| 4KUC | D:21-126; D:127-228; E: | CRYSTAL STRUCTURE OF RICIN-A CHAIN IN COMPLEX WITH THE ANTIBODY 6C2 |
| 4KUZ | L:1-112 | CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM |
| 4L5F | L:1-107; L:108-213 | CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII |
| 4LAQ | H:; L: | CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE |
| 4LAR | L: | CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE |
| 4LAS | L: | CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE |
| 4LEO | B:1-113 | CRYSTAL STRUCTURE OF ANTI-HER3 FAB RG7116 IN COMPLEX WITH THE EXTRACELLULAR DOMAINS OF HUMAN HER3 (ERBB3) |
| 4LEX | L:1-112 | UNLIGANDED CRYSTAL STRUCTURE OF MAB7 |
| 4LF3 | A:1-106; D:1-106 | INHIBITORY MECHANISM OF AN ALLOSTERIC ANTIBODY TARGETING THE GLUCAGON RECEPTOR |
| 4LVH | C:1-110; F:1-110; I:1-110; L:1-110 | INSIGHT INTO HIGHLY CONSERVED H1 SUBTYPE-SPECIFIC EPITOPES IN INFLUENZA VIRUS HEMAGGLUTININ |
| 4M43 | L:1-107 | CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11 |
| 4M48 | L:1-108; L:109-214 | X-RAY STRUCTURE OF DOPAMINE TRANSPORTER ELUCIDATES ANTIDEPRESSANT MECHANISM |
| 4M61 | A:1-112; C:1-112 | CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52 |
| 4M7K | L:1-113 | CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10 |
| 4MA7 | L:1-107 | CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE |
| 4MA8 | L:1-107 | CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE |
| 4MAU | L:1-111 | CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244 |
| 4NCC | 1:1-106; L:1-106 | NEUTRALIZING ANTIBODY TO MURINE NOROVIRUS |
| 4NOB | A: | CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220] |
| 4NX3 | | [entry was replaced by entry 4WEB without any SCOP domain information] |
)
)